Within the immunosuppressive tumor microenvironment, T cells progressively upregulate inhibitory receptors including PD-1 and TIM-3, resulting in compromised cytotoxic capacity and diminished effector cytokine production [4,17]. The gene discussed is HAVCR2; the disease is neoplasm.